Abeona Therapeutics (ABEO) Stock Forecast, Price Target & Predictions
ABEO Stock Forecast
Abeona Therapeutics stock forecast is as follows: an average price target of $6.00 (represents a 3.63% upside from ABEO’s last price of $5.79) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
ABEO Price Target
ABEO Analyst Ratings
Buy
Abeona Therapeutics Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Nov 14, 2022 | - | Leerink Partners | $6.00 | $4.15 | 44.58% | 3.63% |
10
Abeona Therapeutics Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $5.79 | $5.79 | $5.79 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jul 03, 2024 | H.C. Wainwright | - | Buy | Initialise |
May 16, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
Nov 14, 2022 | SVB Leerink | Market Perform | Market Perform | Hold |
10
Abeona Therapeutics Financial Forecast
Abeona Therapeutics Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 22 | Mar 22 | Dec 20 | Sep 20 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Jun 15 | Mar 12 | Mar 11 | Jun 10 | Sep 09 | Jun 08 | Jun 02 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | $68.00K | $346.00K | $3.00M | $7.00M | - | - | - | $2.60M | $186.00K | $235.00K | $282.00K | $1.85M | $150.00K | $105.00K | $144.00K | - | - |
Avg Forecast | $13.93M | $4.25M | $125.00K | $125.00K | $100.00K | $100.00K | $100.00K | $166.67K | $1.00M | $253.73K | $5.37M | $1.40M | $120.00K | $300.00K | $778.50K | $559.44K | $219.23K | $183.53K | $232.65K | $2.58M | $160.71K | $172.86K | $87.03K | $118.53K | $216.67K |
High Forecast | $13.93M | $4.25M | $125.00K | $125.00K | $100.00K | $100.00K | $100.00K | $166.83K | $1.00M | $304.48K | $5.37M | $1.40M | $120.00K | $300.00K | $778.50K | $671.33K | $263.07K | $220.23K | $279.18K | $3.09M | $192.86K | $207.43K | $104.43K | $142.24K | $260.00K |
Low Forecast | $13.93M | $4.25M | $125.00K | $125.00K | $100.00K | $100.00K | $100.00K | $166.50K | $1.00M | $202.99K | $5.37M | $1.40M | $120.00K | $300.00K | $778.50K | $447.55K | $175.38K | $146.82K | $186.12K | $2.06M | $128.57K | $138.28K | $69.62K | $94.82K | $173.33K |
# Analysts | 1 | 1 | 1 | 4 | 6 | 3 | 3 | 3 | 4 | 17 | 10 | 16 | 8 | 10 | 16 | 18 | 20 | 19 | 10 | 14 | 10 | 15 | 10 | 11 | 8 |
Surprise % | - | - | - | - | - | - | - | - | 0.07% | 1.36% | 0.56% | 5.00% | - | - | - | 4.64% | 0.85% | 1.28% | 1.21% | 0.72% | 0.93% | 0.61% | 1.65% | - | - |
Forecast
Abeona Therapeutics EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 22 | Mar 22 | Dec 20 | Sep 20 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Jun 15 | Mar 12 | Mar 11 | Jun 10 | Sep 09 | Jun 08 | Jun 02 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 4 | 6 | 3 | 3 | 3 | 4 | 17 | 10 | 16 | 8 | 10 | 16 | 18 | 20 | 19 | 10 | 14 | 10 | 15 | 10 | 11 | 8 |
EBITDA | - | - | - | - | - | - | - | - | $-10.37M | $-13.31M | $-13.34M | $-4.81M | $-15.34M | $-21.87M | $-16.90M | $-8.29M | $-5.00M | $-5.37M | $-3.98M | $-4.67M | $-1.67M | $1.99M | $-3.87M | - | - |
Avg Forecast | $-8.36M | $-2.55M | $-75.00K | $-75.00K | $-60.00K | $-60.00K | $-60.00K | $-100.00K | $-600.00K | $-9.52M | $-3.22M | $-840.00K | $-72.00K | $-180.00K | $-13.20M | $-8.72M | $-5.66M | $-3.72M | $-3.13M | $-11.41M | $-1.78M | $-103.71K | $-1.67M | $-1.83M | $-1.46M |
High Forecast | $-8.36M | $-2.55M | $-75.00K | $-75.00K | $-60.00K | $-60.00K | $-60.00K | $-99.90K | $-600.00K | $-7.62M | $-3.22M | $-840.00K | $-72.00K | $-180.00K | $-10.56M | $-6.98M | $-4.53M | $-2.97M | $-2.51M | $-9.12M | $-1.43M | $-82.97K | $-1.33M | $-1.46M | $-1.17M |
Low Forecast | $-8.36M | $-2.55M | $-75.00K | $-75.00K | $-60.00K | $-60.00K | $-60.00K | $-100.10K | $-600.00K | $-11.43M | $-3.22M | $-840.00K | $-72.00K | $-180.00K | $-15.84M | $-10.47M | $-6.79M | $-4.46M | $-3.76M | $-13.69M | $-2.14M | $-124.46K | $-2.00M | $-2.19M | $-1.75M |
Surprise % | - | - | - | - | - | - | - | - | 17.29% | 1.40% | 4.14% | 5.72% | 213.06% | 121.48% | 1.28% | 0.95% | 0.88% | 1.44% | 1.27% | 0.41% | 0.94% | -19.21% | 2.32% | - | - |
Forecast
Abeona Therapeutics Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 22 | Mar 22 | Dec 20 | Sep 20 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Jun 15 | Mar 12 | Mar 11 | Jun 10 | Sep 09 | Jun 08 | Jun 02 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 4 | 6 | 3 | 3 | 3 | 4 | 17 | 10 | 16 | 8 | 10 | 16 | 18 | 20 | 19 | 10 | 14 | 10 | 15 | 10 | 11 | 8 |
Net Income | - | - | - | - | - | - | - | - | $6.42M | $-20.99M | $-15.83M | $-7.24M | $-17.37M | $-23.92M | $-18.55M | $-8.46M | $-5.25M | $-5.54M | $-4.11M | $-4.89M | $-1.90M | $1.79M | $-4.07M | - | - |
Avg Forecast | $-6.41M | $-14.91M | $-17.95M | $-17.31M | $-16.83M | $-18.87M | $-16.44M | $-24.68M | $-36.06M | $-10.16M | $-128.07M | $-183.56M | $-558.01M | $-467.53M | $-14.50M | $-8.91M | $-5.95M | $-3.84M | $-3.24M | $-11.95M | $-2.03M | $2.44M | $-1.75M | $-1.99M | $-1.85M |
High Forecast | $-6.41M | $-14.91M | $-17.95M | $-16.37M | $-15.97M | $-18.87M | $-16.44M | $-24.68M | $-36.06M | $-8.13M | $-128.07M | $-183.56M | $-558.01M | $-467.53M | $-11.60M | $-7.13M | $-4.76M | $-3.07M | $-2.59M | $-9.56M | $-1.62M | $2.93M | $-1.40M | $-1.59M | $-1.48M |
Low Forecast | $-6.41M | $-14.91M | $-17.95M | $-18.25M | $-17.26M | $-18.87M | $-16.44M | $-24.68M | $-36.06M | $-12.20M | $-128.07M | $-183.56M | $-558.01M | $-467.53M | $-17.40M | $-10.69M | $-7.14M | $-4.61M | $-3.89M | $-14.34M | $-2.43M | $1.95M | $-2.10M | $-2.39M | $-2.22M |
Surprise % | - | - | - | - | - | - | - | - | -0.18% | 2.07% | 0.12% | 0.04% | 0.03% | 0.05% | 1.28% | 0.95% | 0.88% | 1.44% | 1.27% | 0.41% | 0.94% | 0.73% | 2.32% | - | - |
Forecast
Abeona Therapeutics SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 22 | Mar 22 | Dec 20 | Sep 20 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Jun 15 | Mar 12 | Mar 11 | Jun 10 | Sep 09 | Jun 08 | Jun 02 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 4 | 6 | 3 | 3 | 3 | 4 | 17 | 10 | 16 | 8 | 10 | 16 | 18 | 20 | 19 | 10 | 14 | 10 | 15 | 10 | 11 | 8 |
SG&A | - | - | - | - | - | - | - | - | $5.68M | $4.22M | $7.40M | $4.43M | $4.70M | $5.61M | $5.66M | $2.88M | $3.02M | $4.37M | $3.67M | $979.00K | $1.03M | $1.25M | $3.46M | - | - |
Avg Forecast | $79.68M | $24.32M | $715.24K | $715.24K | $572.19K | $572.19K | $572.19K | $953.66K | $5.72M | $1.43M | $30.22M | $7.88M | $675.71K | $1.69M | $4.38M | $3.15M | $1.23M | $1.03M | $1.31M | $2.39M | $904.96K | $973.34K | $490.04K | $667.43K | $1.22M |
High Forecast | $79.68M | $24.32M | $715.24K | $715.24K | $572.19K | $572.19K | $572.19K | $954.61K | $5.72M | $1.71M | $30.22M | $7.88M | $675.71K | $1.69M | $4.38M | $3.78M | $1.48M | $1.24M | $1.57M | $2.87M | $1.09M | $1.17M | $588.04K | $800.91K | $1.46M |
Low Forecast | $79.68M | $24.32M | $715.24K | $715.24K | $572.19K | $572.19K | $572.19K | $952.70K | $5.72M | $1.14M | $30.22M | $7.88M | $675.71K | $1.69M | $4.38M | $2.52M | $987.56K | $826.74K | $1.05M | $1.91M | $723.96K | $778.66K | $392.02K | $533.94K | $976.01K |
Surprise % | - | - | - | - | - | - | - | - | 0.99% | 2.96% | 0.24% | 0.56% | 6.96% | 3.32% | 1.29% | 0.91% | 2.45% | 4.22% | 2.80% | 0.41% | 1.13% | 1.29% | 7.06% | - | - |
Forecast
Abeona Therapeutics EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 22 | Mar 22 | Dec 20 | Sep 20 | Sep 19 | Jun 19 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | Jun 15 | Mar 12 | Mar 11 | Jun 10 | Sep 09 | Jun 08 | Jun 02 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 4 | 6 | 3 | 3 | 3 | 4 | 17 | 10 | 16 | 8 | 10 | 16 | 18 | 20 | 19 | 10 | 14 | 10 | 15 | 10 | 11 | 8 |
EPS | - | - | - | - | - | - | - | - | $0.82 | $-3.62 | $-4.26 | $-1.93 | $-8.73 | $-12.22 | $-9.67 | $-4.50 | $-3.26 | $-4.23 | $-4.00 | $-253.26 | $-123.37 | $80.09 | $-416.95 | - | - |
Avg Forecast | $-0.13 | $-0.31 | $-0.37 | $-0.36 | $-0.35 | $-0.39 | $-0.34 | $-0.51 | $-0.75 | $-2.38 | $-2.50 | $-3.58 | $-10.89 | $-9.13 | $-7.95 | $-5.00 | $-4.25 | $-2.25 | $-1.77 | $213.75 | $-200.00 | $-187.50 | $-123.75 | $-487.50 | $-750.00 |
High Forecast | $-0.13 | $-0.31 | $-0.37 | $-0.34 | $-0.33 | $-0.39 | $-0.34 | $-0.51 | $-0.75 | $-2.38 | $-2.50 | $-3.58 | $-10.89 | $-9.13 | $-7.95 | $-4.00 | $-3.40 | $-1.80 | $-1.42 | $256.50 | $-160.00 | $-150.00 | $-99.00 | $-390.00 | $-600.00 |
Low Forecast | $-0.13 | $-0.31 | $-0.37 | $-0.38 | $-0.36 | $-0.39 | $-0.34 | $-0.51 | $-0.75 | $-2.38 | $-2.50 | $-3.58 | $-10.89 | $-9.13 | $-7.95 | $-6.00 | $-5.10 | $-2.70 | $-2.13 | $171.00 | $-240.00 | $-225.00 | $-148.50 | $-585.00 | $-900.00 |
Surprise % | - | - | - | - | - | - | - | - | -1.09% | 1.52% | 1.70% | 0.54% | 0.80% | 1.34% | 1.22% | 0.90% | 0.77% | 1.88% | 2.26% | -1.18% | 0.62% | -0.43% | 3.37% | - | - |
Forecast
Abeona Therapeutics Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
CALA | Calithera Biosciences | $0.01 | $2.00 | 19900.00% | Hold |
ATHA | Athira Pharma | $0.66 | $18.00 | 2627.27% | Buy |
IVVD | Invivyd | $0.70 | $9.50 | 1257.14% | Buy |
XFOR | X4 Pharmaceuticals | $0.37 | $3.67 | 891.89% | Buy |
CABA | Cabaletta Bio | $1.87 | $16.33 | 773.26% | Buy |
RVPH | Reviva Pharmaceuticals | $1.24 | $10.00 | 706.45% | Buy |
BDTX | Black Diamond Therapeutics | $2.43 | $14.75 | 507.00% | Buy |
CKPT | Checkpoint Therapeutics | $3.47 | $20.00 | 476.37% | Buy |
INZY | Inozyme Pharma | $2.69 | $14.67 | 445.35% | Buy |
ADAP | Adaptimmune Therapeutics | $0.64 | $2.83 | 342.19% | Buy |
PDSB | PDS Bio | $2.20 | $9.00 | 309.09% | Buy |
ANEB | Anebulo Pharmaceuticals | $1.50 | $6.00 | 300.00% | Buy |
RGNX | REGENXBIO | $9.18 | $32.00 | 248.58% | Buy |
DAWN | Day One Biopharmaceuticals | $13.34 | $38.80 | 190.85% | Buy |
AFMD | Affimed | $2.64 | $7.50 | 184.09% | Buy |
TERN | Terns Pharmaceuticals | $5.71 | $14.25 | 149.56% | Buy |
LPTX | Leap Therapeutics | $2.58 | $5.50 | 113.18% | Buy |
MREO | Mereo BioPharma Group | $3.68 | $6.75 | 83.42% | Buy |
ACAD | ACADIA Pharmaceuticals | $16.18 | $26.57 | 64.22% | Buy |
ABEO | Abeona Therapeutics | $5.79 | $6.00 | 3.63% | Buy |